Overexpression of RLIP76 Required for Proliferation in Meningioma Is Associated with Recurrence

作者: Song-Yuan Fan , Jian-Dong Jiang , Jun Qian , Yi-Cheng Lu , Guo-Han Hu

DOI: 10.1371/JOURNAL.PONE.0125661

关键词:

摘要: The GTPase-activating protein RLIP76 is overexpressed in and correlates with the pathological grade of many malignant tumor cells. But potential correlation between clinical outcomes patients meningioma remains unknown. In this study, we examined expression correlated to patient outcome. tissues was immunohistochemistry, quantitative reverse-transcription polymerase chain reaction(RT-PCR) Western-blot. Immunohistochemistry showed an increased immunostaining score anaplastic atypical meningiomas versus classical meningiomas. Statistical analyses revealed that positively for Ki-67, a nuclear highly expressed proliferating cells(r=0.29, p=0.034 by Spearman's coefficient). Clinicopathological evaluation suggested be associated recurrence(P<0.05). Univariate Cox analysis indicated independent prognostic factor recurrence. Furthermore, human cell lines IOMM-Lee CH157-MN stably transfected short hairpin RNA (siRNA) targeting were then vitro growth assays, apoptosis assays. knockdown cells inhibited proliferation induced apoptosis. Western blot underexpressing exhibited decreased B-cell lymphoma-2(Bcl-2) but effector caspase-3 expression. These findings demonstrate high poor outcome may provide new gene therapy approach

参考文章(31)
Mahlon D. Johnson, Ann Woodard, Evelyn J. Okediji, Steven A. Toms, George S. Allen, Lovastatin is a potent inhibitor of meningioma cell proliferation: evidence for inhibition of a mitogen associated protein kinase. Journal of Neuro-oncology. ,vol. 56, pp. 133- 142 ,(2002) , 10.1023/A:1014588214966
Carine Rossé, Sébastien L'Hoste, Nicolas Offner, André Picard, Jacques Camonis, RLIP, an Effector of the Ral GTPases, Is a Platform for Cdk1 to Phosphorylate Epsin during the Switch Off of Endocytosis in Mitosis Journal of Biological Chemistry. ,vol. 278, pp. 30597- 30604 ,(2003) , 10.1074/JBC.M302191200
Lei Jiang, Tao Wang, Yi Bao, Jun Qian, Xiao‐Jun Wu, Guo‐Han Hu, Yi‐Cheng Lu, None, A study of UbcH10 expression and its association with recurrence of meningiomas Journal of Surgical Oncology. ,vol. 106, pp. 327- 331 ,(2012) , 10.1002/JSO.22141
Kenneth Drake, Jyotsana Singhal, Sushma Yadav, Aalok Nadkar, Chirag Pungaliya, Sharad Singhal, Sanjay Awasthi, RALBP1/RLIP76 mediates multidrug resistance. International Journal of Oncology. ,vol. 30, pp. 139- 144 ,(2007) , 10.3892/IJO.30.1.139
Sharad S. Singhal, Cherice Roth, Kathryn Leake, Jyotsana Singhal, Sushma Yadav, Sanjay Awasthi, Regression of prostate cancer xenografts by RLIP76 depletion Biochemical Pharmacology. ,vol. 77, pp. 1074- 1083 ,(2009) , 10.1016/J.BCP.2008.11.013
Rafael De la Garza-Ramos, Jessica V. Flores-Rodríguez, Juan Carlos Martínez-Gutiérrez, Alejandro Ruiz-Valls, Enrique Caro-Osorio, Current standing and frontiers of gene therapy for meningiomas Neurosurgical Focus. ,vol. 35, ,(2013) , 10.3171/2013.8.FOCUS13305
Yanzhong Hu, Nahid F. Mivechi, HSF-1 interacts with Ral-binding protein 1 in a stress-responsive, multiprotein complex with HSP90 in vivo. Journal of Biological Chemistry. ,vol. 278, pp. 17299- 17306 ,(2003) , 10.1074/JBC.M300788200
Sanjay Awasthi, Sharad S. Singhal, Yogesh C. Awasthi, Bryan Martin, Jung-Hee Woo, C. Casey Cunningham, Arthur E. Frankel, RLIP76 and Cancer Clinical Cancer Research. ,vol. 14, pp. 4372- 4377 ,(2008) , 10.1158/1078-0432.CCR-08-0145
Sanjay Awasthi, Sharad Singhal, Jyotsana Singhal, Jizhong Cheng, Piotr Zimniak, Yogesh Awasthi, Role of RLIP76 in lung cancer doxorubicin resistance: II. Doxorubicin transport in lung cancer by RLIP76. International Journal of Oncology. ,vol. 22, pp. 713- 720 ,(2003) , 10.3892/IJO.22.4.713